{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:37:48Z","timestamp":1792013868334,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005774","name":"Universitat de Barcelona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017167","name":"International Centre for Theoretical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005347","name":"American Association for the Study of Liver Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005053","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Bioingenier\u00eda, Biomateriales y Nanomedicina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119711","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:45:30Z","timestamp":1783032330000},"page":"119711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Microfluidic human liver slices reveal antifibrotic effects of liraglutide via HSC deactivation and ECM remodeling"],"prefix":"10.1016","volume":"201","author":[{"given":"Mar\u00eda","family":"Andr\u00e9s-Rozas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2911-7870","authenticated-orcid":false,"given":"Peio","family":"Aristu-Zabalza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Chullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiliam","family":"Fundora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Folguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabel","family":"Fern\u00e1ndez-Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5748-1074","authenticated-orcid":false,"given":"Sergi","family":"Guix\u00e9-Muntet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7736-4089","authenticated-orcid":false,"given":"Jordi","family":"Gracia-Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119711_bib1","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The Global Burden of Liver Disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119711_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3350\/cmh.2024.0734","article-title":"Sinusoidal communication in chronic liver disease","volume":"31","author":"Gibert-Ramos","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119711_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.biopha.2026.119711_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41575-025-01068-6","article-title":"Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease","volume":"22","author":"Schwabe","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119711_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.addr.2017.07.014","article-title":"The good and the bad collagens of fibrosis \u2013 Their role in signaling and organ function","volume":"121","author":"Karsdal","year":"2017","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119711_bib6","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1089\/ars.2013.5697","article-title":"Extracellular matrix and liver disease","volume":"21","author":"Arriazu","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biopha.2026.119711_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s43152-021-00030-3","article-title":"Extracellular matrix remodeling in chronic liver disease","volume":"2","author":"Ortiz","year":"2021","journal-title":"Curr. Tissue Microenviron. Rep."},{"key":"10.1016\/j.biopha.2026.119711_bib8","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jcmgh.2023.01.014","article-title":"Modeling nonalcoholic fatty liver disease in the dish using human-specific platforms: strategies and limitations","volume":"15","author":"Rezvani","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119711_bib9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jcmgh.2022.11.008","article-title":"Vitro models for the study of liver biology and diseases: advances and limitations","volume":"15","author":"Kaur","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119711_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s13770-025-00719-8","article-title":"Recent advances in three-dimensional in vitro models for studies of liver fibrosis","author":"Chi","year":"2025","journal-title":"Tissue Eng. Regen. Med."},{"key":"10.1016\/j.biopha.2026.119711_bib11","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.3390\/ijms22137137","article-title":"Best practices and progress in precision-cut liver slice cultures","volume":"22","author":"Dewyse","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119711_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000558","article-title":"Precision-cut liver slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosis","volume":"8","author":"Wang","year":"2024","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.biopha.2026.119711_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.actbio.2020.08.041","article-title":"Microfluidic organ-on-a-chip models of human liver tissue","volume":"116","author":"Moradi","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2026.119711_bib14","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.30651","article-title":"A bioreactor technology for modeling fibrosis in human and rodent precision-cut liver slices","volume":"70","author":"Paish","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119711_bib15","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/bit.26776","article-title":"Resemblance of the human liver sinusoid in a fluidic device with biomedical and pharmaceutical applications","volume":"115","author":"Ortega-Ribera","year":"2018","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biopha.2026.119711_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/dom.12591","article-title":"Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors","volume":"18","author":"Nauck","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.biopha.2026.119711_bib17","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119711_bib18","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41598-017-02866-y","article-title":"Liraglutide improves liver microvascular dysfunction in cirrhosis: evidence from translational studies","volume":"7","author":"de Mesquita","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119711_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2012.08.026","article-title":"The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial\u2013stellate cell deactivation induced by statins","volume":"58","author":"Marrone","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119711_bib20","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2026.119711_bib21","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119711_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-026-04733-y","article-title":"Sinusoidal cell-derived biomarker scores predict diagnosis and prognosis in chronic liver disease","author":"Guix\u00e9-Muntet","year":"2026","journal-title":"BMC Med."},{"key":"10.1016\/j.biopha.2026.119711_bib23","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119711_bib24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119711_bib25","article-title":"GTX-11 improves portal hypertension, liver fibrosis, and sinusoidal cells phenotype in experimental MASH","volume":"7","author":"Andr\u00e9s-Rozas","year":"2025","journal-title":"JHEP Rep."},{"key":"10.1016\/j.biopha.2026.119711_bib26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","article-title":"CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics","volume":"20","author":"Jin","year":"2025","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2026.119711_bib27","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.celrep.2019.10.024","article-title":"Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis","volume":"29","author":"Dobie","year":"2019","journal-title":"Cell. Rep."},{"key":"10.1016\/j.biopha.2026.119711_bib28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.pathol.2020.07.018","article-title":"Electron microscopic observations in perfusion-fixed human non-alcoholic fatty liver disease biopsies","volume":"53","author":"Verhaegh","year":"2021","journal-title":"Pathology"},{"key":"10.1016\/j.biopha.2026.119711_bib29","doi-asserted-by":"crossref","DOI":"10.15252\/msb.202210947","article-title":"Dynamic human liver proteome atlas reveals functional insights into disease pathways","volume":"18","author":"Niu","year":"2022","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.biopha.2026.119711_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2026.119711_bib31","unstructured":"Bahijri, S. et al. Fibroblast Growth Factor 21: A More Effective Biomarker Than Free Fatty Acids and Other Insulin Sensitivity Measures for Predicting Non-alcoholic Fatty Liver Disease in Saudi Arabian Type 2 Diabetes Patients. Cureus 15, e50524."},{"key":"10.1016\/j.biopha.2026.119711_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40139-013-0018-7","article-title":"Reversibility of liver fibrosis and inactivation of fibrogenic myofibroblasts","volume":"1","author":"Liu","year":"2013","journal-title":"Curr. Pathobiol. Rep."},{"key":"10.1016\/j.biopha.2026.119711_bib33","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00018-024-05507-6","article-title":"GLP-1 and GIP agonism has no direct actions in human hepatocytes or hepatic stellate cells","volume":"81","author":"da Silva Lima","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2026.119711_bib34","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell. Metab."},{"key":"10.1016\/j.biopha.2026.119711_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat9284","article-title":"Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis","volume":"11","author":"Yang","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2026.119711_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s12276-022-00781-5","article-title":"Hyaluronan synthase 2, a target of miR-200c, promotes carbon tetrachloride-induced acute and chronic liver inflammation via regulation of CCL3 and CCL4","volume":"54","author":"Kim","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119711_bib37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fphar.2018.00553","article-title":"DNA methylation of PTGIS enhances hepatic stellate cells activation and liver fibrogenesis","volume":"9","author":"Pan","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119711_bib38","first-page":"1954","article-title":"ELOVL fatty acid elongase 7 (ELOVL7), upregulated by Mdr2-knockout, predicts advanced liver fibrosis in patients with chronic hepatitis B","volume":"27","author":"Wang","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2026.119711_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/a-2551-3320","article-title":"Alcohol-metabolizing enzymes, liver diseases and cancer","volume":"45","author":"Liu","year":"2025","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.biopha.2026.119711_bib40","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2020.04.037","article-title":"Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation","volume":"73","author":"Bates","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119711_bib41","doi-asserted-by":"crossref","first-page":"615","DOI":"10.7150\/ijms.51589","article-title":"MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression","volume":"18","author":"Li","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.biopha.2026.119711_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/biomedicines9040365","article-title":"Hepatic stellate cell activation and inactivation in NASH-fibrosis\u2014roles as putative treatment targets?","volume":"9","author":"Zisser","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2026.119711_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41420-025-02406-y","article-title":"Insulin-induced gene 2 alleviates ischemia-reperfusion injury in steatotic liver by inhibiting GPX4-dependent ferroptosis","volume":"11","author":"Wu","year":"2025","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.biopha.2026.119711_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117208","article-title":"Targeting AKT to treat liver disease: opportunities and challenges","volume":"242","author":"Wang","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119711_bib45","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1038\/s41598-018-27686-6","article-title":"vitro inhibition of hepatic stellate cell activation by the autophagy-related lipid droplet protein ATG2A","volume":"8","author":"Hong","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119711_bib46","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.3390\/ijms25147873","article-title":"Liver fibrosis: from basic science towards clinical progress, focusing on the central role of hepatic stellate cells","volume":"25","author":"Akk\u0131z","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119711_bib47","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis \u2014 aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119711_bib48","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S2468-1253(23)00438-7","article-title":"Pathophysiology and therapeutic options for cirrhotic portal hypertension","volume":"9","author":"Guix\u00e9-Muntet","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119711_bib49","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/liv.15174","article-title":"Liver regeneration: cellular origin and molecular mechanisms","volume":"42","author":"Huang","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2026.119711_bib50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","article-title":"Liver regeneration: biological and pathological mechanisms and implications","volume":"18","author":"Michalopoulos","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119711_bib51","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.addr.2003.08.002","article-title":"Collagens--structure, function, and biosynthesis","volume":"55","author":"Gelse","year":"2003","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119711_bib52","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1001\/jamainternmed.2024.4661","article-title":"GLP-1 receptor agonists and risk for cirrhosis and related complications in patients with metabolic dysfunction-associated steatotic liver disease","volume":"184","author":"Kanwal","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.biopha.2026.119711_bib53","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000411","article-title":"Plasticity, heterogeneity, and multifunctionality of hepatic stellate cells in liver pathophysiology","volume":"8","author":"Du","year":"2024","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.biopha.2026.119711_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jhep.2009.10.030","article-title":"NF-\u03baB signalling: Embracing complexity to achieve translation","volume":"52","author":"Chakraborty","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119711_bib55","doi-asserted-by":"crossref","first-page":"H240","DOI":"10.1111\/1750-3841.13157","article-title":"Resveratrol regulates activated hepatic stellate cells by modulating NF-\u03baB and the PI3K\/Akt signaling pathway","volume":"81","author":"Zhang","year":"2016","journal-title":"J. Food Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600747X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600747X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:44:04Z","timestamp":1784529844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222600747X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":55,"alternative-id":["S075333222600747X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119711","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microfluidic human liver slices reveal antifibrotic effects of liraglutide via HSC deactivation and ECM remodeling","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119711"}}